BIGBEAR
PHARMACEUTICAL
Anagrelide is an oral thrombocytopenic agent that belongs to the class of phosphodiesterase 3 (PDE3) inhibitors.
AuthenticGuaranteeFast DeliveryPrivacy Composition of Anagrelide(1) Anagrelide hydrochloride, USP is a platelet-reducing agent. Its chemical name is 6,7-dichloro-1,5-dihydroimidazo[2,1-b]qu···【More】
Update: 17 Jul,2026Source: BigbearViews: 96
Anagrelide Adverse Reactions1、Cardiac disorders: Prinzmetal angina, torsade de pointes.2、Respiratory, thoracic and mediastinal disorders: Interstitial···【More】
Update: 16 Jul,2026Source: BigbearViews: 101
Anagrelide capsules, oral, first approved in the United States in 1997. Anagrelide is a platelet-reducing agent indicated for the treatment of thrombo···【More】
Update: 15 Jul,2026Source: BigbearViews: 102
Anagrelide Side Effect Management for Healthcare Professionals1. General Adverse EventsVery common (10% or more): edema (20.6%).Common (1% to 10%): pe···【More】
Update: 15 Jul,2026Source: BigbearViews: 102
Anagrelide may cause different side effects during treatment. If the patient has limited knowledge about the side effects of Anagrelide, it is recomme···【More】
Update: 14 Jul,2026Source: BigbearViews: 98
Anagrelide Use in Special Populations1. Renal ImpairmentIn patients with moderate renal impairment, a single 1 mg dose showed an 8-fold increase in to···【More】
Update: 14 Jul,2026Source: BigbearViews: 95
Anagrelide dosage and administration are related to age and disease type. For specific use, it is recommended to consult a physician and follow medica···【More】
Update: 14 Jul,2026Source: BigbearViews: 96
Anagrelide capsules, for oral administration, were first approved for marketing in the United States in 1997. Anagrelide is a thrombocytopenic agent i···【More】
Update: 08 May,2026Source: BigbearViews: 173
Anagrelide requires close monitoring of its potential side effects, methods of relief, and proper storage to ensure therapeutic efficacy and minimize ···【More】
Update: 10 Mar,2026Source: BigbearViews: 162
Anagrelide, a thrombocytopenic drug, plays an important role in the treatment of certain hematological diseases. Its clinical application requires str···【More】
Update: 10 Mar,2026Source: BigbearViews: 157
In addition to its expected therapeutic effects, selumetinib may cause some adverse reactions. While not all side effects will occur, medical interven···【More】
Update: 10 Mar,2026Source: BigbearViews: 148
Anagrelide is a platelet-reducing agent, also known as a platelet production inhibitor. Domestically produced Anagrelide capsules were launched in Chi···【More】
Update: 04 Mar,2026Source: BigbearViews: 137
Anagrelide is a selective platelet-producing inhibitor, approved for marketing in the United States in 1997, and subsequently approved in Europe and o···【More】
Update: 04 Mar,2026Source: BigbearViews: 140
Anagrelide is primarily used to treat thrombocytosis, especially essential thrombocytosis, reducing the risk of thrombosis and improving patients'···【More】
Update: 04 Mar,2026Source: BigbearViews: 140
Drug Interactions1.Concomitant use of this product with drugs that prolong the QT interval is prohibited (including but not limited to: clarithromycin···【More】
Update: 27 Feb,2026Source: BigbearViews: 151
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos
